Publications by authors named "Evan Cherry"

Claim this Profile
V
Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.
Evan M Cherry, Diana Abbott, Maria Amaya, Christine McMahon, Marc Schwartz

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The propriety of upgrading responses to venetoclax + azacitidine in newly diagnosed patients with acute myeloid leukemia.
Diana Abbott, Evan Cherry, Maria Amaya, Christine McMahon, Marc Schwartz

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant.
Prashant Sharma, Enkhtsetseg Purev, Bradley Haverkos, Daniel A Pollyea, Evan Cherry

Blood Adv· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and testing a comprehensive tool to assess family meetings: Empirical distinctions between high- and low-quality meetings.
Courtenay R Bruce, Alana D Newell, Jonathan H Brewer, Divina O Timme, Evan Cherry

J Crit Care· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Evan M Cherry, Dong W Lee, Ji-Ung Jung, Raquel Sitcheran

Mol Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma.
Steve A Maxwell, Evan M Cherry, Kayla J Bayless

Leuk Lymphoma· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis